Skip to content

Comparison of lateral internal sphincterotomy and botulinum toxin injection in treatment of chronic anal fissure

Comparison of lateral internal sphincterotomy and botulinum toxin injection in treatment of chronic anal fissure

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201011285263N1
Enrollment
86
Registered
2011-02-03
Start date
2010-08-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic anal fissure. chronic anal fissure

Interventions

Intervention 1: Intervention group: the patients set in knee chest position and single dose of botax, under local anesthesia is injected (25units) in internal sphincter in sitution of 3 and 9 o'clock.
Treatment - Drugs
Treatment - Surgery
Intervention group: the patients set in knee chest position and single dose of botax, under local anesthesia is injected (25units) in internal sphincter in sitution of 3 and 9 o'clock.
Control group: the patients set in trendelenberg position and under general anesthesia about 30 percent of internal muscle sphincter (in 3 oclock sitution) was ligated with knife (number 15)

Sponsors

Vice- chancellor for Reasearch of Hamedan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: diagnosis of chronic anal fissure (presented greater than 6 weeks), presence of triad of (sentinel pile, hypertrophy of papi and fibrosis of bed wound), age between18 and 100 years old Exclusion criteria: combination with other anal diseases such as: hemorrhoid, anal fistula, rectal prolapse and positive history of anorectal surgery, positive history of neuromuscular diseases (myesthenia gravis, multiple sclerosis, amiotrophic lateral sclerosis), breast feeding, pregnancy, positive history of drug consumption consist of aspirin, warfarin, aminoglycosides, chloroquine, aminoglycosides, chloroquine

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Wound healing. Timepoint: one week and two months after discharge. Method of measurement: Complete Wound Healing.

Secondary

MeasureTime frame
Complications. Timepoint: One week and two month after discharge. Method of measurement: Standard form.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Hamid Reza Fereidoonin

Hamedan University of Medical Sciences

h.fereidoonian@umsha.ac.ir+98 81 1264 0049

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026